The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Latysheva N.V.

Filatova E.G.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Osipova V.V.

Research Department of Neurology, Scientific Research Center, I.M. Sechenov First Moscow State Medical University, Moscow, Russia;
Moscow Research Clinical Centre for Neuropsychiatry, Moscow Health Department, Moscow, Russia

Temporomandibular disorder as the most prevalent cause of facial pain: current evidence

Authors:

Latysheva N.V., Filatova E.G., Osipova V.V.

More about the authors

Read: 35992 times


To cite this article:

Latysheva NV, Filatova EG, Osipova VV. Temporomandibular disorder as the most prevalent cause of facial pain: current evidence. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(10):106‑113. (In Russ.)
https://doi.org/10.17116/jnevro2017117101106-113

Recommended articles:

References:

  1. Headache Classification Committee of the International Headache Society (IHS).The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629-808. https://doi.org/10.1177/0333102413485658
  2. De Toledo IP, Conti Réus J, Fernandes M, Porporatti AL, Peres MA, Takaschima A, Linhares MN, Guerra E, De Luca Canto G. Prevalence of trigeminal neuralgia: A systematic review. J Am Dent Assoc. 2016;147(7):570-576. https://doi.org/10.1016/j.adaj.2016.02.014
  3. Manfredini D, Guarda-Nardini L, Winocur E, Piccotti F, Ahlberg J, Lobbezoo F. Research diagnostic criteria for temporomandibular disorders: a systematic review of axis I epidemiologic findings. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2011;112(4):453-462. https://doi.org/10.1016/j.tripleo.2011.04.021
  4. Slade GD, Ohrbach R, Greenspan JD, Fillingim RB, Bair E, Sanders AE, Dubner R, Diatchenko L, Meloto CB, Smith S, Maixner W. Painful temporomandibular disorder: decade of discovery from OPPERA studies. J Dent Res. 2016;95(10):1084-1092. https://doi.org/10.1177/0022034516653743
  5. Macfarlane TV, Blinkhorn AS, Davies RM, Kincey J, Worthington HV. Oro-facial pain in the community: prevalence and associated impact. Community Dent Oral Epidemiol. 2002;30(1):52-60. https://doi.org/10.1034/j.1600-0528.2002.300108.x
  6. Hanahok HYu, Skorikova LA. Muscle-articular dysfunction of the temporomandibular joint at somatic diseases. Mezhdunarodnyi zhurnal prikladnykh i fundamental’nykh issledovanii. 2014;2:194-196. (In Russ.)
  7. Orlova OR, Mingazova LR, Vein AM. Myofascial pain syndrome in the face. Novoe v stomatologii. 2003;1:25-29. (In Russ.)
  8. Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, List T, Svensson P, Gonzalez Y, Lobbezoo F, Michelotti A, Brooks SL, Ceusters W, Drangsholt M, Ettlin D, Gaul C, Goldberg LJ, Haythornthwaite JA, Hollender L, Jensen R, John MT, De Laat A, de Leeuw R, Maixner W, van der Meulen M, Murray GM, Nixdorf DR, Palla S, Petersson A, Pionchon P, Smith B, Visscher CM, Zakrzewska J, Dworkin SF. International RDC/TMD Consortium Network, International association for Dental Research.; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache. 2014;28(1):6-27. https://doi.org/10.11607/jop.1151
  9. Mingazova LR, Orlova OR. Myofascial pain syndrome in the face: presentation, diagnostics and treatment with botulinum toxin type A. Effektivnaya farmakoterapiya. 2010;1:36-43. (In Russ.)
  10. Svechtarov V, Nencheva-Svechtarova N, Uzunov Ts. Analysis of chronic temporomandibular disorders based on the latest diagnostic criteria. Acta Medica Bulgarica. 2015:1(XLII):49-55. https://doi.org/10.1515/amb-2015-0007
  11. Ohrbach R, Gonzalez Y, List T, Michelotti A, Schiffman E. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) Clinical Examination Protocol: Version 02 June 2013. Accessed June 25, 2017. www.rdc-tmdinternational.org
  12. Taskaya-Yilmaz N, Ceylan G, Incesu L, Muglali M. A possible etiology of the internal derangement of the temporomandibular joint based on the MRI observations of the lateral pterygoid muscle. Surg Radiol Anat. 2005;27(1):19-24. https://doi.org/10.1007/s00276-004-0267-6
  13. Chisnoiu AM, Picos AM, Popa S, Chisnoiu PD, Lascu L, Picos A, Chisnoiu R. Factors involved in the etiology of temporomandibular disorders — a literature review. Clujul Med. 2015;88(4):473-478. https://doi.org/10.15386/cjmed-485
  14. Galebskaya KYu. Modern view on etiology and treatment of temporomandibular disorder. Uchenye zapiski Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta im. akad. I.P. Pavlova. 2015;22(4):8-12. (In Russ.)
  15. Kindler S, Samietz S, Houshmand M, Grabe HJ, Bernhardt O, Biffar R, Kocher T, Meyer G, Völzke H, Metelmann HR, Schwahn C. Depressive and anxiety symptoms as risk factors for temporomandibular joint pain: a prospective cohort study in the general population. J Pain. 2012;13:1188-1197. https://doi.org/10.1016/j.jpain.2012.09.004
  16. Tournavitis A, Tortopidis D, Fountoulakis K, Menexes G, Koidis P. Psychopathologic profiles of TMD patients with different pain locations. Int J Prosthodont. 2017;30(3):251-257. https://doi.org/10.11607/ijp.5155
  17. Evcik D, Aksoy O. Relationship Between Head Posture and Temporomandibular Dysfunction Syndrome. J Musculoskeletal Pain. 2004;12(2):19-24. https://doi.org/10.1300/j094v12n02_03
  18. Franco AL, Gonçalves DA, Castanharo SM, Speciali JG, Bigal ME, Camparis CM. Migraine is the most prevalent primary headache in individuals with temporomandibular disorders. J Orofac Pain. 2010;24(3):287-292.
  19. da Silva A Jr, Costa EC, Gomes JB, Leite FM, Gomez RS, Vasconcelos LP, Krymchantowski A, Moreira P, Teixeira AL. Chronic headache and comorbidities: a two-phase, population-based, cross-sectional study. Headache. 2010;50(8):1306-1312. https://doi.org/10.1111/j.1526-4610.2010.01620.x
  20. List T, Jensen RH. Temporomandibular disorders: Old ideas and new concepts. Cephalalgia. 2017;37(7):692-704. https://doi.org/10.1177/0333102416686302
  21. Zenkevich AS, Filatova EG, Latysheva NV. Migraine and temporomandibular joint dysfunction: mechanisms of comorbidity. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;115(10):33-38. (In Russ.)
  22. Zenkevich AS, Filatova EG, Latysheva NV. Migraine and comorbid pain. Meditsinskii sovet. 2016;8(10):106-111. (In Russ.)
  23. Kress HG, Baltov A, Basiński A, Berghea F, Castellsague J, Codreanu C, Copaciu E, Giamberardino MA, Hakl M, Hrazdira L, Kokavec M, Lejčko J, Nachtnebl L, Stančík R, Švec A, Tóth T, Vlaskovska MV, Woroń J. Acute pain: a multifaceted challenge — the role of nimesulide. Curr Med Res Opin. 2016;32(1):23-36. https://doi.org/10.1185/03007995.2015.1100986
  24. Bennett A, Tavares IA. COX-2 inhibitors compared and contrasted. Expert Opin Pharmacother. 2001;2:1859-1876. https://doi.org/10.1517/14656566.2.11.1859
  25. Bianchi M, Broggini M. A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee. Drugs. 2003;63(suppl 1):37-46. https://doi.org/10.2165/00003495-200363001-00006
  26. Wober W, Rahlfs VW, Büchl N, Grässle A, Macciocchi A.Comparative efficacy and safety of the non-steroidal anti-inflammatory drugs nimesulide and diclofenac in patients with acute subdeltoid bursitis and bicipital tendinitis. Int J Clin Pract. 1998;52:169-175.
  27. Suleyman H, Cadirci E, Albayrak A, Halici Z. Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug. Curr Med Chem. 2008;15:278-283. https://doi.org/10.2174/092986708783497247
  28. Rajan R, Sun YM. Reevaluating antidepressant selection in patients with bruxism and temporomandibular joint disorder. J Psychiatr Pract. 2017;23(3):173-179. https://doi.org/10.1097/pra.0000000000000227
  29. Connelly ST, Myung J, Gupta R, Tartaglia GM, Gizdulich A, Yang J, Silva R. Clinical outcomes of Botox injections for chronic temporomandibular disorders: do we understand how Botox works on muscle, pain, and the brain? Int J Oral Maxillofac Surg. 2017;46(3):322-327. https://doi.org/10.1016/j.ijom.2016.11.004
  30. Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015;91(6):378-386.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.